Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCL Regimen for R/R PTCL
NCT07072221Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Nov 2024
- Primary completion
- Aug 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of bendamustine, tucidinostat and lenalidomide in peripheral T-cell lymphoma (PTCL) (2 cohorts), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Complete Response Rate. Started Nov 2024; status: recruiting.
02
Drugs
bendamustinetucidinostatlenalidomide
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT07072221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07072221.